Results 191 to 200 of about 1,592,818 (259)

Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis

Molecular Oncology, EarlyView.
LBR‐driven nuclear fragility supports melanoma invasion. A: Melanocyte presents low LBR (Lamin B Receptor) levels, maintaining nuclear integrity and lamina‐chromatin tethering. B: During malignant progression, upregulation of LBR clusters at the INM (Inner Nuclear Membrane) during confined migration causes local lamina weakening and cholesterol ...
Francesca Lorenzini, Maria Caterina Mione   +1 more
wiley   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source

Combined occurrence of cardiovascular and bone events in individuals with kidney stone disease. [PDF]

Clin Kidney J
Ferraro PM, Taylor EN, Gambaro G, Curhan GC.   +3 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Joint modeling of longitudinal and time-to-event data for dynamic disease risk prediction using proteomics. [PDF]

Protein Sci
Lindén M, Ammunét T, Välikangas T, Elo LL, Suomi T.   +4 more
europepmc   +1 more source

Neuromorphic Technologies for Neuroengineering: From Adaptive Stimulation to SNN-Based Inference and Deployable Biointerfaces. [PDF]

Sensors (Basel)
Sun Z, Mu A, Hao F, Wang H.
europepmc   +1 more source

Rider dislodgement events in U.S. steeplechase racing: participation outcomes in riders and horses. [PDF]

Inj Epidemiol
Markowitz JS.
europepmc   +1 more source

Caveats on Using Firth's Penalization in the Model-Based Regression Standardization for Rare Diseases. [PDF]

Stat Med
Hashibe S, Hongo W, Shinozaki T.
europepmc   +1 more source